InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,222.68
(
0.16%
)
US TECH 100
17,720.80
(
0.22%
)
Dow Jones
39,512.84
(
0.32%
)
Brent Oil
82.84
(
0.55%
)
Bitcoin
62,528.89
(
1.76%
)
Post# of 23979
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Ster345

Send PM Follow Ignore
Followers 2
Posts 58
Boards Moderated 0
Alias Born 09/18/2017

Ster345

Re: None

Sunday, 09/24/2017 1:27:55 AM

Sunday, September 24, 2017 1:27:55 AM

Post# of 23979
GOVX: Sanofi & "Broadly neutralizing anti-bodies'

Pharma giant Sanofi is going public with groundbreaking HIV platform.

The foundation of the platform is GeoVax research and development going back 12 years.

GeoVax goes unmentioned in the news article.

No matter.

Imo, GOVX will continue to gain momo in coming sessions as the Sanofi/Geovax nexus begins to come into clearer focus.

News link:
http://www.bbc.com/news/health-41351159


GeoVax, Scripps & "Neutralizing antibodies"
https://www.burnet.edu.au/projects/171_development_of_a_novel_prophylactic_vaccine_candidate_for_hiv_1


NOTE: The reason that GOVX dropped the issuance of new shares appears to be that a Sanofi deal is in the works, imo.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up